| Sanofi-Aventis (Suisse) SA - Mutagrip, Suspension zur Injektion | | 00373 | | 21 | | Mutagrip | | Suspension zur Injektion | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 27.08.2012 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus strain A/California/7/2009 (H1N1)-like: Reassortant virus NYMC X-179A) 15 µg, haemagglutininum influenzae A (H3N2) (Virus strain A/Victoria/361/2011 (H3N2)-like: Reassortant virus IVR-165) 15 µg, haemagglutininum influenzae B (virus strain B/Wisconsin/1/2010-like: Reassortant virus NYMC BX-39 derived from B/Hubei-Wujiagang/158/2009) 15 µg.
natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, residues: formaldehydum max. 100 µg, octoxinolum-9 max. 500 µg, ovalbuminum max. 0.05 µg, saccharum nihil, neomycinum nihil, aqua ad iniectabilia q.s. to suspension for 0.5 ml. | | Packungsbestandteile | | Suspension zur Injektion | | | |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
